Financial Architects (New Jersey)’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Financial Architects (New Jersey)’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-139	Closed	-$2K	–	1508
2019 Q1	$2K	Hold	139	–	–	﹤0.01%	1342
2018 Q4	$2K	Hold	139	–	–	﹤0.01%	1238
2018 Q3	$3K	Sell	139 -107	-43%	-$3.25K	﹤0.01%	1308
2018 Q2	$11K	Buy	246 +40	+19%	+$1.83K	﹤0.01%	971
2018 Q1	$13K	Buy	206 +139	+207%	+$9.85K	﹤0.01%	1009
2017 Q4	$5K	Buy	67 +28	+72%	+$2.32K	﹤0.01%	1310
2017 Q3	$4K	Buy	+39	New	+$2.99K	﹤0.01%	1335

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Financial Architects (New Jersey)'s LUMO Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2019, closing a stake of 139 shares — an estimated $2K sold.

Financial Architects (New Jersey) first reported a position in LUMO in Q3 2017 and held it in 7 quarters. The position peaked at $13K in Q1 2018. 68 funds tracked by Wall St. Rank hold LUMO as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 139 Lumos Pharma, Inc. Common Stock shares in Q2 2019, an estimated $2K.
Financial Architects (New Jersey) first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2017 and held it in 7 quarters.
Financial Architects (New Jersey)'s Lumos Pharma, Inc. Common Stock position peaked at $13K in Q1 2018.
68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.